WHO declares international health emergency over Bundibugyo Ebola outbreak in DRC and Uganda

Reinforces WHO's authority in global health governance; highlights vulnerability of fragile states (DRC, Uganda) to disease outbreaks; potential for increased international aid/intervention; demonstrates dependence on external medical resources for emerging pathogens.

Similar to 2014-2016 West African Ebola crisis which killed 11,000+ and exposed weak health infrastructure in developing nations; Bundibugyo variant's lack of approved countermeasures increases uncertainty.

Potential travel restrictions and increased healthcare costs in affected regions; global consumers may face higher prices for medical supplies and vaccines if manufacturing capacity is redirected; increased insurance premiums for travel to Central Africa.

Governments likely to implement border screening and travel advisories; accelerated funding for vaccine/treatment development; potential trade restrictions on goods from DRC/Uganda; increased WHO coordination and emergency funding requests; possible emergency use authorizations for experimental treatments.

Institutional authority framing combined with risk escalation emphasis. The article prioritizes WHO's official declarations and scientific evidence while highlighting worst-case scenarios ('potentially much larger outbreak') and unique danger factors (no approved treatments/vaccines).